Rukiye Yasak Güner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rukiye Yasak Güner has a total of 162 co-authors. Here are the top co-authors by number of shared publications:
- Melih Akyol
Department of Dermatology, Faculty of Medicine, Sivas Cumhuriyet University, 58140 Sivas, Turkey
10 shared publications - Mustafa Tosun
Department of Dermatology, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Türkiye
8 shared publications - Ahmet Turan Ünsal
Department of Dermatology, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Türkiye
5 shared publications Melih Akyol
Dermatology Department Medicine Faculty Sivas Cumhuriyet University Sivas Turkey
5 shared publications- Erkan Alpsoy
Department of Dermatology and Venereology Akdeniz University School of Medicine Antalya Turkey
3 shared publications - Esra Adışen
Department of Dermatology Gazi University Faculty of Medicine Ankara Türkiye
3 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9278
Ferroptosis-Related GPX4 and CD71 and Immune Checkpoint PD-L1 in Cutaneous Melanoma: Associations with Clinicopathologic Features and Survival Outcomes
Ferroptosis-related pathways and immune checkpoint signaling may contribute to melanoma progression, but their clinicopathologic and prognostic interplay remains incompletely characterized. To investigate GPX4, CD71, and PD-L1 expression in primary cutaneous melanoma and evaluate their associations with clinicopathologic features and survival outcomes. This retrospective single-center cohort included 44 patients with primary cutaneous melanoma. PD-L1, GPX4, and CD71 expressions were assessed immunohistochemically. Associations with clinicopathologic parameters were analyzed, and overall survival (OS) and disease-free survival (DFS) were evaluated using Kaplan–Meier and Cox regression analyses. PD-L1, GPX4, and CD71 positivity was were observed in 25.0%, 38.6%, and 36.4% of tumors, respectively. PD-L1 expression was associated with Breslow thickness (p = 0.004), whereas CD71 expression was associated with perineural invasion, Clark level, and disease stage (p = 0.019, p = 0.034, and p = 0.045, respectively). GPX4-positive tumors showed significantly shorter OS (40 vs. 103 months; p = 0.003) and DFS (42 vs. 86 months; p = 0.009). Triple-positive tumors (PD-L1+/GPX4+/CD71+) demonstrated significantly shorter OS and DFS than triple-negative tumors (p = 0.035 and p = 0.040, respectively). In multivariable analysis, GPX4 positivity remained independently associated with poorer OS. GPX4 expression was associated with adverse survival outcomes in cutaneous melanoma, while combined GPX4, CD71, and PD-L1 expression identified a subgroup with particularly unfavorable outcomes. These findings support further investigation of ferroptosis-related markers alongside immune checkpoint pathways as candidate prognostic biomarkers in melanoma.
- 19 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9278
Open AccessFerroptosis-Related GPX4 and CD71 and Immune Checkpoint PD-L1 in Cutaneous Melanoma: Associations with Clinicopathologic Features and Survival Outcomes
Ferroptosis-related pathways and immune checkpoint signaling may contribute to melanoma progression, but their clinicopathologic and prognostic interplay remains incompletely characterized. To investigate GPX4, CD71, and PD-L1 expression in primary cutaneous melanoma and evaluate their associations with clinicopathologic features and survival outcomes. This retrospective single-center cohort included 44 patients with primary cutaneous melanoma. PD-L1, GPX4, and CD71 expressions were assessed immunohistochemically. Associations with clinicopathologic parameters were analyzed, and overall survival (OS) and disease-free survival (DFS) were evaluated using Kaplan–Meier and Cox regression analyses. PD-L1, GPX4, and CD71 positivity was were observed in 25.0%, 38.6%, and 36.4% of tumors, respectively. PD-L1 expression was associated with Breslow thickness (p = 0.004), whereas CD71 expression was associated with perineural invasion, Clark level, and disease stage (p = 0.019, p = 0.034, and p = 0.045, respectively). GPX4-positive tumors showed significantly shorter OS (40 vs. 103 months; p = 0.003) and DFS (42 vs. 86 months; p = 0.009). Triple-positive tumors (PD-L1+/GPX4+/CD71+) demonstrated significantly shorter OS and DFS than triple-negative tumors (p = 0.035 and p = 0.040, respectively). In multivariable analysis, GPX4 positivity remained independently associated with poorer OS. GPX4 expression was associated with adverse survival outcomes in cutaneous melanoma, while combined GPX4, CD71, and PD-L1 expression identified a subgroup with particularly unfavorable outcomes. These findings support further investigation of ferroptosis-related markers alongside immune checkpoint pathways as candidate prognostic biomarkers in melanoma.
- Open Access
Exploring the Immune Microenvironment in Early-Stage Mycosis Fungoides and Large-Plaque Parapsoriasis: Diagnostic and Prognostic Significance of CD47, CD163, and B7-H3
Background and Objectives: Mycosis fungoides (MF) is the predominant subtype of cutaneous T-cell lymphoma, whereas large plaque parapsoriasis (LPP) closely resembles early-stage MF, making differential diagnosis challenging. Immune markers, such as CD47, CD163, and B7-H3, play crucial roles in tumor immune evasion and macrophage polarization. However, their expression profiles and potential diagnostic or prognostic implications in early-stage MF and LPP remain poorly defined. Therefore, this study aimed to evaluate the expression of CD47, CD163, and B7-H3 in early-stage MF and LPP and analyze their associations with clinicopathological characteristics and patient outcomes. Materials and Methods: This retrospective study evaluated the immunohistochemical expression of CD47, CD163, and B7-H3 in 46 patients with early-stage mycosis fungoides (MF) and 46 patients with large plaque parapsoriasis (LPP). Expression levels were assessed using an immunoreactivity scoring system and analyzed for their associations with clinical parameters and disease-free survival (DFS). The study included patients diagnosed and followed at Sivas Cumhuriyet University between 1 March 2015 and 31 March 2025. Results: High CD47 expression was detected in 72.7% of MF patients, high B7-H3 expression in 45.7%, and high CD163 expression in 46.7% compared with LPP patients (p < 0.001). These markers showed positive correlations, and elevated expression, especially of B7-H3 and CD163, was associated with shorter disease-free survival in univariate analysis. Conclusions: The higher expression of CD47, CD163, and B7-H3 in early-stage MF compared with LPP suggests that these markers may contribute to the differential diagnosis and could represent potential therapeutic targets; however, their independent prognostic value requires confirmation in larger studies.
Open AccessExploring the Immune Microenvironment in Early-Stage Mycosis Fungoides and Large-Plaque Parapsoriasis: Diagnostic and Prognostic Significance of CD47, CD163, and B7-H3
Background and Objectives: Mycosis fungoides (MF) is the predominant subtype of cutaneous T-cell lymphoma, whereas large plaque parapsoriasis (LPP) closely resembles early-stage MF, making differential diagnosis challenging. Immune markers, such as CD47, CD163, and B7-H3, play crucial roles in tumor immune evasion and macrophage polarization. However, their expression profiles and potential diagnostic or prognostic implications in early-stage MF and LPP remain poorly defined. Therefore, this study aimed to evaluate the expression of CD47, CD163, and B7-H3 in early-stage MF and LPP and analyze their associations with clinicopathological characteristics and patient outcomes. Materials and Methods: This retrospective study evaluated the immunohistochemical expression of CD47, CD163, and B7-H3 in 46 patients with early-stage mycosis fungoides (MF) and 46 patients with large plaque parapsoriasis (LPP). Expression levels were assessed using an immunoreactivity scoring system and analyzed for their associations with clinical parameters and disease-free survival (DFS). The study included patients diagnosed and followed at Sivas Cumhuriyet University between 1 March 2015 and 31 March 2025. Results: High CD47 expression was detected in 72.7% of MF patients, high B7-H3 expression in 45.7%, and high CD163 expression in 46.7% compared with LPP patients (p < 0.001). These markers showed positive correlations, and elevated expression, especially of B7-H3 and CD163, was associated with shorter disease-free survival in univariate analysis. Conclusions: The higher expression of CD47, CD163, and B7-H3 in early-stage MF compared with LPP suggests that these markers may contribute to the differential diagnosis and could represent potential therapeutic targets; however, their independent prognostic value requires confirmation in larger studies.
- 31 March 2026
- Published by Cumhuriyet University in Cumhuriyet Medical Journal
- Vol. 48 (1) , 24-28
Papillon–Lefèvre Syndrome Associated with a Newly Identified Homozygous c.872G>A Mutation in the CTSC Gene: A Case Report
Papillon–Lefèvre syndrome (PLS) is a rare autosomal recessive genodermatosis caused by pathogenic variants in the CTSC gene. The condition is characterized by the coexistence of palmoplantar keratoderma and early-onset, rapidly progressive periodontitis. Here, we present a 21-year-old female patient in whom a previously unreported homozygous CTSC variant, c.872G>A, was identified.Since childhood, the patient had marked hyperkeratosis on the palmoplantar regions, early tooth loss, and the need for oral prostheses. A family history of individuals with similar dermatologic features and consanguinity between the parents supported an autosomal recessive inheritance pattern. The identified variant was evaluated in conjunction with the clinical phenotype and was classified as likely pathogenic according to the American College of Medical Genetics and Genomics (ACMG) criteria.Systemic retinoid therapy was recommended but could not be initiated due to patient preference. This case contributes to the expanding genetic spectrum of PLS and highlights the crucial importance of early diagnosis, a multidisciplinary approach, and treatment adherence in determining disease prognosis.
- 31 March 2026
- Published by Cumhuriyet University in Cumhuriyet Medical Journal
- Vol. 48 (1) , 24-28
Papillon–Lefèvre Syndrome Associated with a Newly Identified Homozygous c.872G>A Mutation in the CTSC Gene: A Case Report
Papillon–Lefèvre syndrome (PLS) is a rare autosomal recessive genodermatosis caused by pathogenic variants in the CTSC gene. The condition is characterized by the coexistence of palmoplantar keratoderma and early-onset, rapidly progressive periodontitis. Here, we present a 21-year-old female patient in whom a previously unreported homozygous CTSC variant, c.872G>A, was identified.Since childhood, the patient had marked hyperkeratosis on the palmoplantar regions, early tooth loss, and the need for oral prostheses. A family history of individuals with similar dermatologic features and consanguinity between the parents supported an autosomal recessive inheritance pattern. The identified variant was evaluated in conjunction with the clinical phenotype and was classified as likely pathogenic according to the American College of Medical Genetics and Genomics (ACMG) criteria.Systemic retinoid therapy was recommended but could not be initiated due to patient preference. This case contributes to the expanding genetic spectrum of PLS and highlights the crucial importance of early diagnosis, a multidisciplinary approach, and treatment adherence in determining disease prognosis.
- 10 March 2026
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (4) , 829-834
Nail Disorders in Children With Down Syndrome: A Multicenter Study
Background and Objectives: Although skin diseases in Down syndrome (DS) have been investigated, nail disorders remain understudied. This study aims to evaluate the prevalence and clinical characteristics of nail disorders in children with DS. Methods: This is a multicenter, case–control study in which 221 children with DS and 160 healthy children were recruited from 9 tertiary dermatology centers. A detailed nail and skin examination was performed by an experienced dermatologist in each center. Nail disorders were recorded. Results: Of the 221 children with DS, 57% (126/221) had at least one nail disorder. The prevalence of nail disorders in the DS group was significantly higher than in the control group ( p ≤ 0.001). Brittle nail was the most common nail disorder (19.0%, 42/221) in children with DS, followed by Beau's lines and onychomadesis (16.3%, 36/221), longitudinal ridging (12.7%, 28/221), and self‐induced nail disorders (onychophagia, habitual tic deformity, and onychotillomania) (10.0%, 22/221). The risk of any nail disorder was 3 times higher, brittle nails 4.3 times, Beau's lines and onychomadesis 5.6 times, self‐induced nail disorders 1.6 times, and longitudinal ridging 3.4 times higher in DS compared to the control group ( p < 0.05). Conclusions: Nail disorders, including brittle nails, Beau's lines, and onychomadesis, self‐induced nail disorders, and longitudinal ridging, are common in DS. The identification of nail disorders in DS may aid in recognizing underlying systemic or psychiatric conditions, thereby supporting more comprehensive care for children with DS.
- 10 March 2026
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (4) , 829-834
Nail Disorders in Children With Down Syndrome: A Multicenter Study
Background and Objectives: Although skin diseases in Down syndrome (DS) have been investigated, nail disorders remain understudied. This study aims to evaluate the prevalence and clinical characteristics of nail disorders in children with DS. Methods: This is a multicenter, case–control study in which 221 children with DS and 160 healthy children were recruited from 9 tertiary dermatology centers. A detailed nail and skin examination was performed by an experienced dermatologist in each center. Nail disorders were recorded. Results: Of the 221 children with DS, 57% (126/221) had at least one nail disorder. The prevalence of nail disorders in the DS group was significantly higher than in the control group ( p ≤ 0.001). Brittle nail was the most common nail disorder (19.0%, 42/221) in children with DS, followed by Beau's lines and onychomadesis (16.3%, 36/221), longitudinal ridging (12.7%, 28/221), and self‐induced nail disorders (onychophagia, habitual tic deformity, and onychotillomania) (10.0%, 22/221). The risk of any nail disorder was 3 times higher, brittle nails 4.3 times, Beau's lines and onychomadesis 5.6 times, self‐induced nail disorders 1.6 times, and longitudinal ridging 3.4 times higher in DS compared to the control group ( p < 0.05). Conclusions: Nail disorders, including brittle nails, Beau's lines, and onychomadesis, self‐induced nail disorders, and longitudinal ridging, are common in DS. The identification of nail disorders in DS may aid in recognizing underlying systemic or psychiatric conditions, thereby supporting more comprehensive care for children with DS.
- Open Access
- 21 February 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 101 (1)
Comentário sobre “A relação das respostas do FricTest com um escore de atividade da urticária, teste de controle da urticária e escalas de qualidade de vida nos pacientes com dermografismo sintomático” ‐ Resposta
- 21 February 2026
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 101 (1)
Open AccessComentário sobre “A relação das respostas do FricTest com um escore de atividade da urticária, teste de controle da urticária e escalas de qualidade de vida nos pacientes com dermografismo sintomático” ‐ Resposta
- Open Access
- 26 October 2025
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (4) , 234-239
Self-reported COVID-19 prevalence among isotretinoin users vs. non-users: a cross-sectional survey
Aim: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic, and effective drug treatments for COVID-19 remain unavailable. Isotretinoin (ISO), a retinoic acid derivative commonly used for severe acne, is a potent down-regulator of ACE2 receptors, which play a key role in the pathophysiology of COVID-19. This study aims to investigate the effect of ISO treatment on COVID-19 infection in patients with acne vulgaris. Materials and Methods: Between January 2021 and April 2021, 520 ISO users with acne vulgaris and 400 controls were included in the study. Data were collected using an electronic questionnaire distributed via social media, e-mail and mobile phones. Results: Among ISO users, 66 (12.7%) had COVID-19 compared to 89 (22.3%) in the control group, indicating a significantly lower infection rate in the ISO group (p
- 26 October 2025
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (4) , 234-239
Open AccessSelf-reported COVID-19 prevalence among isotretinoin users vs. non-users: a cross-sectional survey
Aim: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic, and effective drug treatments for COVID-19 remain unavailable. Isotretinoin (ISO), a retinoic acid derivative commonly used for severe acne, is a potent down-regulator of ACE2 receptors, which play a key role in the pathophysiology of COVID-19. This study aims to investigate the effect of ISO treatment on COVID-19 infection in patients with acne vulgaris. Materials and Methods: Between January 2021 and April 2021, 520 ISO users with acne vulgaris and 400 controls were included in the study. Data were collected using an electronic questionnaire distributed via social media, e-mail and mobile phones. Results: Among ISO users, 66 (12.7%) had COVID-19 compared to 89 (22.3%) in the control group, indicating a significantly lower infection rate in the ISO group (p
- Open Access
- 26 October 2025
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (4) , 234-239
Self-reported COVID-19 prevalence among isotretinoin users vs. non-users: a cross-sectional survey
Aim: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic, and effective drug treatments for COVID-19 remain unavailable. Isotretinoin (ISO), a retinoic acid derivative commonly used for severe acne, is a potent down-regulator of ACE2 receptors, which play a key role in the pathophysiology of COVID-19. This study aims to investigate the effect of ISO treatment on COVID-19 infection in patients with acne vulgaris. Materials and Methods: Between January 2021 and April 2021, 520 ISO users with acne vulgaris and 400 controls were included in the study. Data were collected using an electronic questionnaire distributed via social media, e-mail and mobile phones. Results: Among ISO users, 66 (12.7%) had COVID-19 compared to 89 (22.3%) in the control group, indicating a significantly lower infection rate in the ISO group (p
- 26 October 2025
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (4) , 234-239
Open AccessSelf-reported COVID-19 prevalence among isotretinoin users vs. non-users: a cross-sectional survey
Aim: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic, and effective drug treatments for COVID-19 remain unavailable. Isotretinoin (ISO), a retinoic acid derivative commonly used for severe acne, is a potent down-regulator of ACE2 receptors, which play a key role in the pathophysiology of COVID-19. This study aims to investigate the effect of ISO treatment on COVID-19 infection in patients with acne vulgaris. Materials and Methods: Between January 2021 and April 2021, 520 ISO users with acne vulgaris and 400 controls were included in the study. Data were collected using an electronic questionnaire distributed via social media, e-mail and mobile phones. Results: Among ISO users, 66 (12.7%) had COVID-19 compared to 89 (22.3%) in the control group, indicating a significantly lower infection rate in the ISO group (p
- Open Access
- 7 July 2025
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 100 (5)
The relationship of FricTest® responses with an urticaria activity score, urticaria control test and quality of life scales in patients with symptomatic dermographism
- 7 July 2025
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 100 (5)
Open AccessThe relationship of FricTest® responses with an urticaria activity score, urticaria control test and quality of life scales in patients with symptomatic dermographism